This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Aug 1;4(145):145fs25.

doi: 10.1126/scitranslmed.3004440.

Anti-CD25 immunotherapy: regulating the regulators

Affiliations

Affiliation

¹ Neurovirology Research Laboratory, Veterans Affairs Salt Lake City Health Care System and Department of Neurology, School of Medicine, University of Utah, Salt Lake City, UT 84148, USA.

PMID: 22855460
DOI: 10.1126/scitranslmed.3004440

Comment

Anti-CD25 immunotherapy: regulating the regulators

John W Rose. Sci Transl Med. 2012.

. 2012 Aug 1;4(145):145fs25.

doi: 10.1126/scitranslmed.3004440.

Author

Affiliation

¹ Neurovirology Research Laboratory, Veterans Affairs Salt Lake City Health Care System and Department of Neurology, School of Medicine, University of Utah, Salt Lake City, UT 84148, USA.

PMID: 22855460
DOI: 10.1126/scitranslmed.3004440

No abstract available

PubMed Disclaimer

Comment on

Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis.
Perry JS, Han S, Xu Q, Herman ML, Kennedy LB, Csako G, Bielekova B. Perry JS, et al. Sci Transl Med. 2012 Aug 1;4(145):145ra106. doi: 10.1126/scitranslmed.3004140. Sci Transl Med. 2012. PMID: 22855463 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information